A phase I trial of bortezomib with temozolomide in patients with advanced melanoma: Toxicities, antitumor effects, and modulation of therapeutic targets
Yingjun Su, Katayoun I. Amiri, Linda W. Horton, Yingchun Yu, Gregory D. Ayers, Elizabeth Koehler, Mark C. Kelley, Igor Puzanov, Ann Richmond, Jeffrey A. Sosman
Dive into the research topics of 'A phase I trial of bortezomib with temozolomide in patients with advanced melanoma: Toxicities, antitumor effects, and modulation of therapeutic targets'. Together they form a unique fingerprint.